Skip to main content
. 2012 Aug 10;17(8):9573–9589. doi: 10.3390/molecules17089573

Table 5.

Effects of trachylobane-360 isolated from Xylopia langsdorffiana on the hematological parameters on peripheral blood. Mice were inoculated with sarcoma 180 (25 × 106 cells/mL, s.c.). The animals were treated for seven consecutive days, starting one day after tumor implantation.

Drug Dose(mg/kg) Total leukocytes (103 mm−3) Differential count of leukocytes (%)
Lymphocytes Neutrophils Monocytes Eosinophils
Healthy mice
(5% Tween-80) - 7.08 ± 0.51 77.80 ± 3.73 18.40 ± 3.25 3.40 ± 0.51 0.40 ± 0.24
Control-S180
(5% Tween-80) - 13.34 ± 2.58 c 44.00 ± 2.54 c 50.50 ± 3.16 c 4.33 ± 0.56 0.67 ± 0.33
5-FU 25 3.95 ± 0.51 a 77.17 ± 2.18 a 18.50 ± 2.32a 3.50 ± 0.62 0.50 ± 0.34
Trachylobane-360 12.5 11.15 ± 1.28 b 51.83 ± 4.66 b,c 41.17 ± 5.25 b,c 6.00 ± 1.57 1.00 ± 0.45
Trachylobane-360 25 11.42 ± 0.92 b 53.17 ± 5.08 b,c 38.67 ± 4.56 b,c 6.83 ± 1.11 0.50 ± 0.22

Data are presented as mean ± SEM of six animals. a p < 0.05 compared to control-S180 by ANOVA followed by Tukey; b p < 0.05 compared to mice transplanted with tumor S180 and treated with 5-FU, by ANOVA followed by Tukey’s test; c p < 0.05 compared to healthy mice, by ANOVA followed by Tukey’s test.

HHS Vulnerability Disclosure